CD10+ GPR77 + CAFs enriched a survival niche for cancer stem cells (CSCs), enhanced tumor formation, and induced cancer chemoresistance by secreting IL-6 leading to driving the activation of NF-κB via p65 phosphorylation and acetylation, which maintained by complement signaling via GPR77 [27]. The gene discussed is NFKB1; the disease is neoplasm.